{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:07:17Z","timestamp":1791860837310,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T00:00:00Z","timestamp":1668643200000},"content-version":"vor","delay-in-days":1173,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1111\/ajt.15507","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T14:19:19Z","timestamp":1561040359000},"page":"2457-2467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Cytomegalovirus prevention strategies and the risk of BK polyomavirus viremia and nephropathy"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5404-598X","authenticated-orcid":false,"given":"Tomas","family":"Reischig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kacer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3236-3127","authenticated-orcid":false,"given":"Ondrej","family":"Hes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Machova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Nemcova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Lysak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Jindra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristyna","family":"Pivovarcikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislav","family":"Kormunda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Bouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1111\/ajt.15507_bib1","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.kint.2018.05.018","article-title":"Analyses of the short- and long-term graft survival after kidney transplantation in Europe between 1986 and 2015","volume":"94","author":"Coemans","year":"2018","journal-title":"Kidney Int."},{"issue":"suppl 4","key":"10.1111\/ajt.15507_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/ajt.12110","article-title":"BK polyomavirus in solid organ transplantation","volume":"13","author":"Hirsch","year":"2013","journal-title":"Am J Transplant."},{"issue":"11","key":"10.1111\/ajt.15507_bib3","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1097\/TP.0000000000001333","article-title":"BK polyomavirus and the transplanted kidney: immunopathology and therapeutic approaches","volume":"100","author":"Lamarche","year":"2016","journal-title":"Transplantation."},{"issue":"8","key":"10.1111\/ajt.15507_bib4","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1111\/ajt.14292","article-title":"BK virus nephropathy: histological evolution by sequential pathology","volume":"17","author":"Nankivell","year":"2017","journal-title":"Am J Transplant."},{"issue":"8","key":"10.1111\/ajt.15507_bib5","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1111\/ajt.14314","article-title":"Histological evolution of BK virus-associated nephropathy: importance of integrating clinical and pathological findings","volume":"17","author":"Drachenberg","year":"2017","journal-title":"Am J Transplant."},{"issue":"6","key":"10.1111\/ajt.15507_bib6","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/TP.0000000000002191","article-title":"The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"102","author":"Kotton","year":"2018","journal-title":"Transplantation."},{"issue":"6","key":"10.1111\/ajt.15507_bib7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3851\/IMP3129","article-title":"The impact of viral load and time to onset of cytomegalovirus replication on long-term graft survival after kidney transplantation","volume":"22","author":"Reischig","year":"2017","journal-title":"Antivir Ther."},{"issue":"2","key":"10.1111\/ajt.15507_bib8","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1600-6143.2009.02952.x","article-title":"BK-virus and the impact of pre-emptive immunosuppression reduction: 5-year results","volume":"10","author":"Hardinger","year":"2010","journal-title":"Am J Transplant."},{"issue":"20","key":"10.1111\/ajt.15507_bib9","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1001\/jama.2014.14721","article-title":"Levofloxacin for BK virus prophylaxis following kidney transplantation: a randomized clinical trial","volume":"312","author":"Knoll","year":"2014","journal-title":"JAMA."},{"issue":"9","key":"10.1111\/ajt.15507_bib10","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/TP.0b013e3181d0e15e","article-title":"Treatment of polyomavirus infection in kidney transplant recipients: a systematic review","volume":"89","author":"Johnston","year":"2010","journal-title":"Transplantation."},{"issue":"7","key":"10.1111\/ajt.15507_bib11","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/ndt\/gfy346","article-title":"Reducing calcineurin inhibitor first for treating BK polyomavirus replication after kidney transplantation: long-term outcomes","volume":"34","author":"Bischof","year":"2019","journal-title":"Nephrol Dial Transplant."},{"issue":"8","key":"10.1111\/ajt.15507_bib12","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1111\/ajt.13791","article-title":"The cell biology of cytomegalovirus: implications for transplantation","volume":"16","author":"Kaminski","year":"2016","journal-title":"Am J Transplant."},{"issue":"2","key":"10.1111\/ajt.15507_bib13","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jcv.2006.01.015","article-title":"The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection","volume":"36","author":"Reischig","year":"2006","journal-title":"J Clin Virol."},{"issue":"11","key":"10.1111\/ajt.15507_bib14","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1681\/ASN.2013101052","article-title":"Cytomegalovirus-responsive gammadelta T cells: novel effector cells in antibody-mediated kidney allograft microcirculation lesions","volume":"25","author":"Bachelet","year":"2014","journal-title":"J Am Soc Nephrol."},{"issue":"10","key":"10.1111\/ajt.15507_bib15","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/infdis\/jit064","article-title":"Cytomegalovirus exposure and cardiovascular disease in kidney transplant recipients","volume":"207","author":"Courivaud","year":"2013","journal-title":"J Infect Dis."},{"issue":"1","key":"10.1111\/ajt.15507_bib16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1523-1755.2004.00735.x","article-title":"Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival","volume":"66","author":"Sagedal","year":"2004","journal-title":"Kidney Int."},{"issue":"9","key":"10.1111\/ajt.15507_bib17","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1681\/ASN.2009111188","article-title":"Subclinical viremia increases risk for chronic allograft injury in pediatric renal transplantation","volume":"21","author":"Smith","year":"2010","journal-title":"J Am Soc Nephrol."},{"issue":"9","key":"10.1111\/ajt.15507_bib18","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1111\/j.1600-6143.2006.01413.x","article-title":"Prophylactic versus preemptive oral valganciclovir for the management of cytomegalovirus infection in adult renal transplant recipients","volume":"6","author":"Khoury","year":"2006","journal-title":"Am J Transplant."},{"issue":"1","key":"10.1111\/ajt.15507_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1600-6143.2007.02031.x","article-title":"Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation","volume":"8","author":"Reischig","year":"2008","journal-title":"Am J Transplant."},{"issue":"9","key":"10.1111\/ajt.15507_bib20","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1681\/ASN.2012010100","article-title":"Long-term outcomes of pre-emptive valganciclovir compared with valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation","volume":"23","author":"Reischig","year":"2012","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"10.1111\/ajt.15507_bib21","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2215\/CJN.07020714","article-title":"Randomized trial of valganciclovir versus valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation","volume":"10","author":"Reischig","year":"2015","journal-title":"Clin J Am Soc Nephrol."},{"issue":"5","key":"10.1111\/ajt.15507_bib22","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/j.1600-6143.2010.03074.x","article-title":"The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients","volume":"10","author":"Humar","year":"2010","journal-title":"Am J Transplant."},{"issue":"1","key":"10.1111\/ajt.15507_bib23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1600-6143.2012.04320.x","article-title":"Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study","volume":"13","author":"Hirsch","year":"2013","journal-title":"Am J Transplant."},{"issue":"12","key":"10.1111\/ajt.15507_bib24","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1097\/TP.0b013e3182921995","article-title":"Risk factors for BK virus infection in the era of therapeutic drug monitoring","volume":"95","author":"Borni-Duval","year":"2013","journal-title":"Transplantation."},{"issue":"9","key":"10.1111\/ajt.15507_bib25","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/tri.12601","article-title":"Different risk factor profiles distinguish early-onset from late-onset BKV-replication","volume":"28","author":"Schachtner","year":"2015","journal-title":"Transpl Int."},{"issue":"1","key":"10.1111\/ajt.15507_bib26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/ajt.13880","article-title":"Pretransplantation donor-recipient pair seroreactivity against BK polyomavirus predicts viremia and nephropathy after kidney transplantation","volume":"17","author":"Wunderink","year":"2017","journal-title":"Am J Transplant."},{"issue":"4","key":"10.1111\/ajt.15507_bib27","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/TP.0000000000001066","article-title":"Viral origin, clinical course, and renal outcomes in patients with BK virus infection after living-donor renal transplantation","volume":"100","author":"Schwarz","year":"2016","journal-title":"Transplantation."},{"issue":"12","key":"10.1111\/ajt.15507_bib28","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/TP.0b013e3182a6890d","article-title":"CMV viremia is associated with a decreased incidence of BKV reactivation after kidney and kidney-pancreas transplantation","volume":"96","author":"Elfadawy","year":"2013","journal-title":"Transplantation."},{"key":"10.1111\/ajt.15507_bib29","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ebiom.2018.07.017","article-title":"BKV, CMV, and EBV interactions and their effect on graft function one year post-renal transplantation: results from a large multi-centre study","volume":"34","author":"Blazquez-Navarro","year":"2018","journal-title":"EBioMedicine."},{"issue":"2","key":"10.1111\/ajt.15507_bib30","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/01.TP.0000165110.78397.93","article-title":"Co-infection of polyomavirus-BK and cytomegalovirus in renal transplant recipients","volume":"80","author":"Toyoda","year":"2005","journal-title":"Transplantation."},{"issue":"1","key":"10.1111\/ajt.15507_bib31","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1186\/s12879-018-3493-y","article-title":"Less renal allograft fibrosis with valganciclovir prophylaxis for cytomegalovirus compared to high-dose valacyclovir: a parallel group, open-label, randomized controlled trial","volume":"18","author":"Reischig","year":"2018","journal-title":"BMC Infect Dis."},{"issue":"2","key":"10.1111\/ajt.15507_bib32","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1681\/ASN.2017050477","article-title":"The Banff working group classification of definitive polyomavirus nephropathy: morphologic definitions and clinical correlations","volume":"29","author":"Nickeleit","year":"2018","journal-title":"J Am Soc Nephrol."},{"issue":"2","key":"10.1111\/ajt.15507_bib33","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant."},{"issue":"12","key":"10.1111\/ajt.15507_bib34","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1128\/JCM.39.12.4357-4361.2001","article-title":"Detection and differentiation of human polyomaviruses JC and BK by LightCycler PCR","volume":"39","author":"Whiley","year":"2001","journal-title":"J Clin Microbiol."},{"key":"10.1111\/ajt.15507_bib35","first-page":"CD003774","article-title":"Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients","volume":"2","author":"Hodson","year":"2013","journal-title":"Cochrane Database Syst Rev."},{"issue":"5","key":"10.1111\/ajt.15507_bib36","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1097\/TP.0000000000002024","article-title":"Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients: long-term results after 7 years of a randomized clinical trial","volume":"102","author":"Witzke","year":"2018","journal-title":"Transplantation."},{"issue":"suppl 1","key":"10.1111\/ajt.15507_bib37","first-page":"156","article-title":"Successful cost-effective prevention of cytomegalovirus disease in kidney transplant recipients using low-dose valganciclovir","volume":"15","author":"Gheith","year":"2017","journal-title":"Exp Clin Transplant."},{"issue":"1","key":"10.1111\/ajt.15507_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/tid.12644","article-title":"Ureteral stent duration and the risk of BK polyomavirus viremia or bacteriuria after kidney transplantation","volume":"19","author":"Wingate","year":"2017","journal-title":"Transpl Infect Dis."},{"issue":"6","key":"10.1111\/ajt.15507_bib39","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1172\/JCI115217","article-title":"Inhibition of immune functions by antiviral drugs","volume":"87","author":"Heagy","year":"1991","journal-title":"J Clin Invest."},{"issue":"7","key":"10.1111\/ajt.15507_bib40","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bbmt.2007.03.009","article-title":"Ganciclovir inhibits lymphocyte proliferation by impairing DNA synthesis","volume":"13","author":"Battiwalla","year":"2007","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1111\/ajt.15507_bib41","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jcv.2015.12.012","article-title":"In vitro studies of the impact of maribavir on CMV-specific cellular immune responses","volume":"75","author":"Stachel","year":"2016","journal-title":"J Clin Virol."},{"issue":"8","key":"10.1111\/ajt.15507_bib42","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3851\/IMP1879","article-title":"Valganciclovir prophylaxis against cytomegalovirus impairs lymphocyte proliferation and activation in renal transplant recipients","volume":"16","author":"Reischig","year":"2011","journal-title":"Antivir Ther."},{"issue":"6","key":"10.1111\/ajt.15507_bib43","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/cid\/cis993","article-title":"Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study","volume":"56","author":"Manuel","year":"2013","journal-title":"Clin Infect Dis."},{"issue":"6","key":"10.1111\/ajt.15507_bib44","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1111\/ajt.13684","article-title":"The \u201cABC\u201d of virus-specific T cell immunity in solid organ transplantation","volume":"16","author":"Sester","year":"2016","journal-title":"Am J Transplant."},{"issue":"8","key":"10.1111\/ajt.15507_bib45","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1111\/ajt.13252","article-title":"The loss of BKV-specific immunity from pretransplantation to posttransplantation identifies kidney transplant recipients at increased risk of BKV replication","volume":"15","author":"Schachtner","year":"2015","journal-title":"Am J Transplant."},{"issue":"6","key":"10.1111\/ajt.15507_bib46","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1097\/TP.0000000000001314","article-title":"Increased frequency of BK virus-specific polyfunctional CD8+ T cells predict successful control of BK viremia after kidney transplantation","volume":"101","author":"Schaenman","year":"2017","journal-title":"Transplantation."},{"issue":"6","key":"10.1111\/ajt.15507_bib47","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1111\/ajt.12218","article-title":"Pathology of resolving polyomavirus-associated nephropathy","volume":"13","author":"Menter","year":"2013","journal-title":"Am J Transplant."},{"issue":"11","key":"10.1111\/ajt.15507_bib48","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1111\/ajt.13911","article-title":"Antigen-specificity of T Cell infiltrates in biopsies with T cell-mediated rejection and BK polyomavirus viremia: analysis by next generation sequencing","volume":"16","author":"Zeng","year":"2016","journal-title":"Am J Transplant."},{"issue":"4","key":"10.1111\/ajt.15507_bib49","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1681\/ASN.2016030285","article-title":"Polyomavirus reactivation and immune responses to kidney-specific self-antigens in transplantation","volume":"28","author":"Seifert","year":"2017","journal-title":"J Am Soc Nephrol."},{"issue":"4","key":"10.1111\/ajt.15507_bib50","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1681\/ASN.2014010119","article-title":"Persistent BK viremia does not increase intermediate-term graft loss but is associated with de novo donor-specific antibodies","volume":"26","author":"Sawinski","year":"2015","journal-title":"J Am Soc Nephrol."},{"issue":"6","key":"10.1111\/ajt.15507_bib51","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1681\/ASN.2016070797","article-title":"Antibody-mediated rejection due to preexisting versus de novo donor-specific antibodies in kidney allograft recipients","volume":"28","author":"Aubert","year":"2017","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"10.1111\/ajt.15507_bib52","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1681\/ASN.2017050532","article-title":"Neutralizing antibody-mediated response and risk of BK virus-associated nephropathy","volume":"29","author":"Solis","year":"2018","journal-title":"J Am Soc Nephrol."},{"issue":"25","key":"10.1111\/ajt.15507_bib53","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N Engl J Med."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajt.15507","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15507","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.15507","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522092218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522092218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.15507","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:23:42Z","timestamp":1761629022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522092218"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S1600613522092218"],"URL":"https:\/\/doi.org\/10.1111\/ajt.15507","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytomegalovirus prevention strategies and the risk of BK polyomavirus viremia and nephropathy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.15507","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}